| Bilateral Cataract after Taking Oxcarbazepine. |
|
Hyo Jeong Kim, Na Yeon Jung, Chan Min Yang, Tae Young Chung, Dong Hui Lim |
1Department of Ophthalmology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. ldhlse@gmail.com
2Department of Preventive Medicine, Graduate School, The Catholic University of Korea, Seoul, Korea. |
| 옥스카르바제핀 복용 후 발생한 양안의 백내장 |
|
김효정1⋅정나연1⋅양찬민1⋅정태영1⋅임동희1,2 |
|
성균관대학교 의과대학 삼성서울병원 안과학교실1, 가톨릭대학교 예방의학교실2 |
Correspondence:
Dong Hui Lim,
Email: ldhlse@gmail.com
|
|
Received: 7 June 2018 • Revised: 25 August 2018 • Accepted: 23 April 2019 |
| Abstract |
PURPOSE
To report a case of bilateral posterior subcapsular cataract after taking oxcarbazepine (Trileptal®, Novartis, Basel, Swiss). CASE SUMMARY: A 19-year-old female visited our clinic with decreased vision in both eyes. Her best-corrected visual acuity was 0.3 in the right eye and 0.5 in the left eye, and slit-lamp examination revealed a bilateral cortical opacity and subcapsular cataract. She had been taking oxcarbazepine for epilepsy for 10 years, which was discontinued 3 years ago. Her mother had undergone cataract surgeries when she was approximately 46 years of age. No other risk factors for cataract were present. CONCLUSIONS: In the present case, bilateral cortical opacity and subcapsular cataract were assumed to be associated with the use of oxcarbazepine. We suggest that oxcarbazepine could induce a cataract and recommend a regular follow-up by a qualified ophthalmologist. |
| Key Words:
Anti epileptic drugs;Oxcarbazepine;Subcapsular cataract |
|
PDF Links
Full text via DOI
Download Citation
